| Literature DB >> 30859793 |
Elias Zgheib1, Elsy Ramia2, Souheil Hallit3,4,5, Christa Boulos6, Pascale Salameh1,5,7.
Abstract
The objective is to describe disability risk factors in Lebanese elderly living in rural settings, focusing on the role of polypharmacy, alcohol consumption, and nutrition. The Aging and Malnutrition in Elderly Lebanese study, a cross-sectional population-based one (April 2011-April 2012), included 1200 individuals aged ≥65 years from 24 Lebanese rural districts. The results showed that 288 (24%) were disabled and 287 (23.9%) exposed to polypharmacy. More disabled participants were found among patients exposed to polypharmacy (40.8%) than those who were not (18.8%). Major classes associated with disability were "Parkinson" and "Alzheimer" medications, with "alcohol consumption" being responsible for a major interaction with medications. Chronic diseases, nutrition, and socioeconomic status also had a large effect on disability. Skin ulcer (ORa = 8.569; CI 5.330-14.823), followed by dementia (ORa = 3.667; CI 1.167-8.912), and anti-gout drugs (ORa = 3.962; CI 1.290-7.622) were found to be significantly associated with increased odds of disability the most. Many factors are associated with disability among elderly, including polypharmacy and the association of medications with alcohol. Counseling of the elderly caregivers is warranted. © Atlantis Press International B.V.Entities:
Keywords: Activities of daily living; disability; elderly; functional status; polypharmacy
Mesh:
Year: 2018 PMID: 30859793 PMCID: PMC7325811 DOI: 10.2991/j.jegh.2018.08.002
Source DB: PubMed Journal: J Epidemiol Glob Health ISSN: 2210-6006
Percentages of “disabled participants” between different groups of sociodemographic variables
| Governorate | <0.001 | ||
| Mount Lebanon | 66 (22%) | 234 (78%) | |
| North Lebanon | 53 (17.7%) | 247 (82.3%) | |
| South Lebanon | 48 (32.2%) | 102 (67.8%) | |
| Nabatieh | 64 (32.0%) | 136 (68.0%) | |
| Bekaa | 57 (22.8%) | 197 (77.2%) | |
| Age | <0.001 | ||
| <80 years | 169 (18.6%) | 741 (81.4%) | |
| ≥80 years | 119 (41.1%) | 171 (58.9%) | |
| Sex | 0.005 | ||
| Male | 121 (20.5%) | 471 (79.5%) | |
| Female | 167 (27.5%) | 441 (72.5%) | |
| Monthly income | 0.029 | ||
| <600,000 LBP | 222 (25.7%) | 638 (74.3%) | |
| >600,000 LBP | 66 (19.4%) | 274 (80.6%) | |
| Insurance/National security coverage | 0.667 | ||
| No | 122 (24.4%) | 370 (75.6%) | |
| Yes | 166 (23.4%) | 542 (76.6%) | |
| Lives alone | 0.004 | ||
| No | 272 (25.2%) | 808 (74.8%) | |
| Yes | 16 (13.5%) | 104 (86.5%) | |
| Number of rooms at home | 0.253 | ||
| ≤3 rooms | 115 (22.5%) | 401 (77.5%) | |
| >3 rooms | 173 (25.4%) | 513 (74.6%) | |
Equivalent to US$400.
Percentages of disabled participants with respect to regular drug intake
| Polypharmacy | No | 622 | 117 (18.8) | 505 (81.2) | |
| Yes | 419 | 171 (40.8) | 248 (59.6) | ||
| Diuretics | No | 936 | 203 (21.7) | 733 (78.3) | <0.001 |
| Yes | 264 | 85 (32.2) | 179 (67.8) | ||
| Anti-arrhythmic | No | 951 | 222 (23.4) | 729 (76.4) | 0.035 |
| Yes | 249 | 85 (34.2) | 164 (65.8) | ||
| Anti-coagulants | No | 802 | 170 (21.2) | 632 (78.8) | <0.001 |
| Yes | 398 | 118 (29.6) | 280 (70.4) | ||
| Anti-ischemic | No | 1072 | 237 (22.1) | 835 (77.9) | <0.001 |
| Yes | 128 | 51 (39.8) | 77 (60.2) | ||
| Oral anti-diabetics | No | 901 | 191 (21.2) | 710 (78.8) | <0.001 |
| Yes | 292 | 97 (33.2) | 195 (66.8) | ||
| Insulin | No | 1178 | 278 (23.6) | 900 (76.4) | 0.018 |
| Yes | 22 | 10 (45.5) | 12 (54.5) | ||
| NSAID | No | 986 | 216 (21.9) | 770 (78.1) | <0.001 |
| Yes | 214 | 72 (33.6) | 142 (66.4) | ||
| PPI | No | 1015 | 213 (21.0) | 802 (79.0) | <0.001 |
| Yes | 185 | 74 (40.0) | 111 (60.0) | ||
| Laxatives | No | 1186 | 281 (23.7) | 905 (76.3) | 0.011 |
| Yes | 12 | 7 (58.3) | 5 (41.7) | ||
| Anti-cholinergic | No | 1170 | 272 (23.2) | 898 (76.8) | <0.001 |
| Yes | 30 | 16 (53.3) | 14 (46.7) | ||
| Vitamins supplements | No | 930 | 199 (21.4) | 731 (78.6) | <0.001 |
| Yes | 270 | 89 (33.0) | 181 (67.0) | ||
| Anti-gout | No | 1161 | 265 (22.8) | 896 (77.2) | <0.001 |
| Yes | 39 | 23 (59.0) | 16 (41.0) | ||
| Typical/atypical antipsychotics | No | 1191 | 282 (23.7) | 909 (76.3) | 0.008 |
| Yes | 9 | 6 (66.7) | 3 (33.3) | ||
| SSRI | No | 1174 | 277 (23.6) | 897 (76.4) | 0.027 |
| Yes | 26 | 11 (42.3) | 15 (57.7) | ||
| Alzheimer drugs | No | 1191 | 281 (23.6) | 900 (76.4) | <0.001 |
| Yes | 9 | 7 (77.9) | 2 (82.1) | ||
| Parkinson drugs | No | 1178 | 286 (24) | 905 (76) | <0.001 |
| Yes | 99 | 15 (68.2) | 7 (31.8) | ||
| Muscle relaxants | No | 1184 | 278 (23.5) | 906 (76.5) | <0.001 |
| Yes | 16 | 10 (62.5) | 6 (37.5) |
Only variables significantly associated with disability were shown in this table;
Non steroidal anti-inflammatory drugs;
Proton pump inhibitors;
Specific serotonin reuptake inhibitors.
Association of disability to diet types and lifestyle variables
| Sodium-free diet | 196 (29.8) | 462 (70.2) | <0.001 |
| No sodium-free diet | 98 (17.2) | 472 (82.8) | |
| Low-fat diet | 150 (34.6) | 283 (65.4) | <0.001 |
| No low-fat diet | 135 (17.7) | 628 (82.3) | |
| Diabetes diet | 153 (34.5) | 291 (65.5) | <0.001 |
| No diabetes diet | 132 (17.6) | 618 (82.4) | |
| Low-calories diet | 107 (35.8) | 192 (64.2) | <0.001 |
| No low-calories diet | 178 (19.9) | 716 (80.1) | |
| Fluid diet | 83 (44.9) | 102 (55.1) | <0.001 |
| No fluid diet | 202 (20.0) | 808 (80.0) | |
| Alcohol consumption | 76 (62.8) | 45 (37.2) | <0.001 |
| No alcohol consumption | 209 (19.5) | 863 (80.5) | |
| Smoking | 125 (30.7) | 282 (69.3) | <0.001 |
| No smoking | 162 (20.5) | 628 (79.5) |
This table contains an exhaustive list of the factors that have entered the study from this section.
Impact of potential correlates on functional status (ADL): logistic regressions
| Model 1: Chronic diseases | |||||
| Hypertension | 0.344 | 0.049 | 1.411 | 1.001 | 1.988 |
| Diabetes | 0.479 | 0.005 | 1.614 | 1.154 | 2.257 |
| Cardiac problem | 0.357 | 0.047 | 1.429 | 1.005 | 2.032 |
| Rheumatoid arthritis | 0.326 | 0.093 | 1.385 | 0.947 | 2.025 |
| Parkinson | 1.216 | 0.008 | 3.372 | 1.375 | 8.268 |
| Gastric problem | 0.783 | <0.001 | 2.188 | 1.480 | 3.234 |
| Hearing impairment | 0.772 | <0.001 | 2.163 | 1.511 | 3.099 |
| Skin ulcer | 2.159 | 0.012 | 8.660 | 1.615 | 46.437 |
| Amputation | 2.26 | 0.009 | 9.589 | 1.764 | 52.122 |
| Hyperuricemia | 0.878 | 0.033 | 2.405 | 1.074 | 5.384 |
| Dementia | 1.126 | <0.001 | 3.083 | 1.635 | 5.810 |
| Fracture | 0.762 | 0.005 | 2.142 | 1.259 | 3.645 |
| Model 2: Health status, biometric variables and medication | |||||
| Anti-ischemic | 0.606 | 0.041 | 1.833 | 1.026 | 3.276 |
| PPIs | 0.688 | 0.006 | 1.990 | 1.213 | 3.265 |
| Laxatives | 1.679 | 0.075 | 5.360 | 0.846 | 33.936 |
| Anti-gout | 1.201 | 0.025 | 3.324 | 1.165 | 9.487 |
| Parkinson drugs | 2.450 | 0.006 | 11.590 | 1.985 | 67.668 |
| Insomnia | 0.476 | 0.026 | 1.610 | 1.059 | 2.448 |
| Consults doctor | 0.702 | 0.001 | 2.018 | 1.308 | 3.112 |
| Depression | 0.566 | 0.013 | 1.761 | 1.124 | 2.760 |
| Malnutrition | 1.026 | <0.001 | 2.789 | 1.769 | 4.397 |
| Loneliness | 0.676 | 0.003 | 1.965 | 1.264 | 3.055 |
| Model 3: Diet and habits | |||||
| Smoking | 0.536 | <0.001 | 1.710 | 1.276 | 2.290 |
| Smoking period | −0.428 | 0.009 | 0.652 | 0.474 | 0.897 |
| Diabetic diet | 0.419 | 0.014 | 1.520 | 1.089 | 2.122 |
| Fluid diet | 0.413 | 0.060 | 1.512 | 0.983 | 2.324 |
| Alcohol | 1.541 | <0.001 | 4.668 | 2.967 | 7.344 |
Model 1: Omnibus test (p = 0.001), Hosmer/Lemshow (p = 0.549) tests and the classification table (77.1%) show that the model is adequate to reality and that at least one chronic disease has an effect on the functional status. Also, 22.8% (Nagelkerke R-square) of the variance of the functional status can be explained by chronic diseases. Model 2: Omnibus test (p = 0.001), Hosmer/Lemshow (p = 0.314) tests and the classification table (75.4%) show that the model is adequate to reality and that at least one variable has an effect on the functional status. Also, 31.4% (Nagelkerke R-square) of the variance of the functional status can be explained by the health status, biometric variables, and medication. Model 3: Omnibus test (p = 0.001), Hosmer/Lemshow (p = 0.955) tests and the classification table (79%) show that the model is adequate to reality and that at least one diet habit has an effect on the functional status. Also, 15.7% (Nagelkerke R-square) of the variance of the functional status can be explained by diet habits. In each model, the factors that were retained in the final model were exclusively displayed in the table; PPIs, proton pump inhibitors.
Summary logistic regression model: disability correlates among Lebanese elderly
| Age | 1.066 | <0.001 | 2.904 | 1.012 | 0.000 | 2.752 |
| Live alone | −1.22 | 0.007 | 0.295 | −0.831 | 0.061 | 0.436 |
| Cerebrovascular disease | – | – | – | 0.500 | 0.063 | 1.648 |
| Rheumatoid arthritis | −0.538 | 0.074 | 0.584 | – | – | – |
| Parkinson drugs | 1.180 | 0.087 | 3.253 | – | – | – |
| Gastric disease | 0.561 | 0.071 | 1.753 | 0.811 | 0.007 | 2.250 |
| Hearing impairment | 0.447 | 0.088 | 1.563 | – | – | – |
| Skin ulcer | 2.148 | 0.085 | 8.569 | 2.174 | 0.083 | 8.795 |
| Dementia | 1.299 | 0.027 | 3.667 | 1.364 | 0.015 | 3.911 |
| Fracture | 0.731 | 0.049 | 2.077 | 0.793 | 0.055 | 2.209 |
| Polypharmacy | 0.736 | 0.007 | 2.087 | – | – | – |
| Proton pump inhibitors | 0.549 | 0.075 | 1.731 | – | – | – |
| Anti-gout | 1.377 | 0.032 | 3.962 | 1.357 | 0.065 | 3.883 |
| Nutritional status | 0.736 | 0.005 | 2.088 | 0.589 | 0.026 | 1.803 |
| Loneliness | 0.559 | 0.026 | 1.749 | 0.480 | 0.075 | 1.616 |
| Diabetes diet | 0.422 | 0.098 | 1.525 | 0.546 | 0.038 | 1.726 |
| Alcohol consumption | 0.993 | 0.003 | 2.698 | – | – | – |
Multiple regression model: disability correlates among Lebanese elderly
| Age | −0.017 | −0.121 | <0.001 |
| Live alone | 0.281 | 0.085 | <0.001 |
| Cerebrovascular disease | −0.948 | −0.136 | <0.001 |
| Skin ulcer | −0.687 | −0.072 | 0.002 |
| Dementia | −0.425 | −0.091 | <0.001 |
| Fracture | −0.233 | −0.064 | 0.006 |
| Polypharmacy | −0.027 | −0.083 | 0.001 |
| Nutritional status | 0.098 | 0.428 | <0.001 |
| Diabetes diet | −0.123 | −0.055 | 0.025 |
| Alcohol consumption | 0.093 | 0.059 | 0.116 |